MOYES JAY M
SEC insider (Form 3/4/5 filer). CIK 0001191062. Director at BioCardia, Inc. (BCDA) and 2 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Jul 6, 2026. Located in SUNNYVALE, CA.
Companies MOYES JAY M has filed insider reports for
- BioCardia, Inc. (BCDA): Director
- PUMA BIOTECHNOLOGY, INC. (PBYI): Director
- Sintx Technologies, Inc. (SINT): Director
MOYES JAY M
CIK: 0001191062
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 6, 2026BCDA
BioCardia, Inc.
AwardDirectStock Option (right to buy)
8K shares- - Jun 12, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect22K shares at avg. $7.22$159K - Jun 11, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
AwardDirect27K shares- - Feb 23, 2026SINT
Sintx Technologies, Inc.
PurchaseDirect1K shares at avg. $2.91$3K - Dec 8, 2025BCDA
BioCardia, Inc.
AwardDirectStock Option (right to buy)
12K shares- - Aug 26, 2025SINT
Sintx Technologies, Inc.
PurchaseDirect3K shares at avg. $3.59$11K - Jun 13, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect22K shares at avg. $3.40$75K - Jun 11, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
AwardDirect27K shares- - Oct 11, 2024BCDA
BioCardia, Inc.
AwardDirectStock Option (right to buy)
829 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 6, 2026 |  BCDA BioCardia, Inc. | Award Stock Option (right to buy) | 8,000 | - | - | Direct |
| Jun 12, 2026 |  PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 22,000 | $7.22 | $158,796 | Direct |
| Jun 11, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Award | 27,000 | - | $0 | Direct |
| Feb 23, 2026 |  SINT Sintx Technologies, Inc. | Purchase | 1,000 | $2.91 | $2,910 | Direct |
| Dec 8, 2025 | BCDA BioCardia, Inc. | Award Stock Option (right to buy) | 12,000 | - | - | Direct |
| Aug 26, 2025 | SINT Sintx Technologies, Inc. | Purchase | 3,000 | $3.59 | $10,756 | Direct |
| Jun 13, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 22,000 | $3.40 | $74,800 | Direct |
| Jun 11, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Award | 27,000 | - | - | Direct |
| Oct 11, 2024 | BCDA BioCardia, Inc. | Award Stock Option (right to buy) | 829 | - | - | Direct |
1-9 of 9 transactions